← Leaderboards
Mark Mapstone
University Of Rochester
$2,600,735
Attributed
$2,600,735
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $23M · FY2005–25$25M$18.8M$12.5M$6.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$105,349,470 · 4
By mechanism
U19$102,748,735 · 1
R01$2,035,306 · 1
K23$564,899 · 1
M01$530 · 1
Top collaborators
- Benjamin L Handen11 shared
- Bradley T Christian10 shared
- Elizabeth Head10 shared
Most similar at University Of Rochester
Same institution · by research overlap
- Charles J Duffy$9,449,715
- Edward G Freedman$10,656,621
- Benjamin T Crane$4,615,800
- Mary M Hayhoe$9,400,383
- David C Knill$8,434,190
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseDementiaPublic HealthPre-ClinicalFundingAlzheimerâS Disease BiomarkerResearch PersonnelClinical TrialsGenesFamilyCognitiveParticipantGeneral PopulationHigh RiskAmyloidBiological MarkersDisease ProgressionCohortMetabolomicsNeuropsychologyDown SyndromeBiologyAging Population
Grant awards (21)
Alzheimer Biomarker Consortium - Down Syndrome (ABC-DS)$17,980,649
U19 · FY2025 · AG
Alzheimer Biomarker Consortium - Down Syndrome (ABC-DS)$404,804
U19 · FY2025 · AG
Alzheimer Biomarker Consortium - Down Syndrome (ABC-DS)$21,776,522
U19 · FY2023 · AG
Alzheimer Biomarker Consortium - Down Syndrome (ABC-DS) - KUMC Field Site Supplement$774,896
U19 · FY2023 · AG
Alzheimer Biomarker Consortium - Down Syndrome (ABC-DS) - Supplement$438,809
U19 · FY2023 · AG
Alzheimer Biomarker Consortium - Down Syndrome (ABC-DS)$19,233,560
U19 · FY2022 · AG
ABC-DS MOMsâ Supplement (Modification of Maternal AD risk in DS)$788,668
U19 · FY2022 · AG
Alzheimer Biomarker Consortium - Down Syndrome (ABC-DS)-04 Supplement 5$765,262
U19 · FY2022 · AG
Alzheimer Biomarker Consortium - Down Syndrome (ABC-DS)$19,355,148
U19 · FY2021 · AG
Multi-omic Investigation of Exercise Effects in Mild Cognitive Impairment$469,083
R01 · FY2021 · AG · contact PI
Alzheimer Biomarker Consortium - Down Syndrome (ABC-DS)$250,000
U19 · FY2021 · AG
Alzheimer Biomarker Consortium - Down Syndrome (ABC-DS)$20,980,417
U19 · FY2020 · AG
Multi-omic Investigation of Exercise Effects in Mild Cognitive Impairment$464,150
R01 · FY2020 · AG · contact PI
Multi-omic Investigation of Exercise Effects in Mild Cognitive Impairment$457,484
R01 · FY2019 · AG · contact PI
Multi-omic Investigation of Exercise Effects in Mild Cognitive Impairment$644,589
R01 · FY2018 · AG · contact PI
Attention and Memory Influences on Navigation in Alzheimer's Disease$118,322
K23 · FY2007 · AG · contact PI
Attention and Memory Influences on Navigation in AD$115,585
K23 · FY2006 · AG · contact PI
Attention and Memory Influences on Navigation in AD$112,957
K23 · FY2005 · AG
COGNITIVE, BEHAVIOR, AND HORMONES IN PERIMENOPAUSE$530
M01 · FY2005 · RR
Attention and Memory Influences on Navigation in AD$110,305
K23 · FY2004 · AG
Attention and Memory Influences on Navigation in AD$107,730
K23 · FY2003 · AG